Su Chul Jang

7PUBLICATIONS
26CO-AUTHORS
Gene and molecular therapyMolecular targetsPredictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 18, 2022
Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity.

Sushrut Kamerkar, Charan Leng, Olga Burenkova

|Apr 23, 2021
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance.

Su Chul Jang, Kyriakos D Economides, Raymond J Moniz

|Jan 14, 2021
Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12.

Nuruddeen D Lewis, Chang Ling Sia, Katherine Kirwin

|Mar 05, 2020
Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation.

Rossella Crescitelli, Cecilia Lässer, Su Chul Jang

|Oct 10, 2019
Endosomal signalling via exosome surface TGFβ-1.

Ganesh Vilas Shelke, Yanan Yin, Su Chul Jang

|Sep 10, 2019
DNA analysis of low- and high-density fractions defines heterogeneous subpopulations of small extracellular vesicles based on their DNA cargo and topology.

Elisa Lázaro-Ibáñez, Cecilia Lässer, Ganesh Vilas Shelke

Pageof 2

Frequent Collaborators

4 joint publications

Jan Lötvall

3 joint publications

Rossella Crescitelli

3 joint publications

Aleksander Cvjetkovic

3 joint publications

Cecilia Lässer